Concepedia

Publication | Open Access

Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?

DOIFull Paper Access

190

Citations

7

References

2014

Year

Kathleen K. Christians, Susan Tsai, Anna Mahmoud, Paul S. Ritch, James P. Thomas, Lauren Allison Wiebe, Tracy Kelly, Huamin Wang, Douglas B. Evans, Ben George
The Oncologist

Abstract

FOLFIRINOX followed by chemoradiation as neoadjuvant therapy for borderline resectable pancreatic adenocarcinoma is safe, and our initial experience suggests favorable resection rates compared with previous reports in this high-risk patient population.

References

YearCitations

Page 1